Assessment of neuroleptic-like properties of progesterone

Psychopharmacology

Volumn 143, Issue 1, 1999, Pages 29-38

  Rupprecht, Rainer ^a,d   Koch, Michael ^b   Montkowski, Alexandra ^a   Lancel, Marike ^a   Faulhaber, Johannes ^a   Harting, Jürgen ^c   Spanagel, Rainer ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c MERCK KGAA   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Neuroleptic; Neurosteroids; Progesterone; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; PROGESTERONE;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DYSPHORIA; ELECTROENCEPHALOGRAM; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; WAKEFULNESS;

ANIMALS; ANTIPSYCHOTIC AGENTS; ANXIETY; AVOIDANCE LEARNING; CATALEPSY; DEXTROAMPHETAMINE; DOPAMINE UPTAKE INHIBITORS; ELECTROENCEPHALOGRAPHY; MALE; MOTOR ACTIVITY; PREGNANOLONE; PROGESTERONE; RATS; RATS, WISTAR; STARTLE REACTION; STEREOTYPED BEHAVIOR;

EID: 0032900939     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050916     Document Type: Article

References (48)

1. 2 autoreceptor agonist. J Pharmacol Exp Ther 276:41-48
2. Bäckström T, Zetterlund B, Blom S, Romano M (1984) Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol Scand 69:240-248
3. Biedermann K, Schoch P (1985) Do neuroactive steroids cause fatigue in pregnancy? Eur J Obstet Gynecol Reprod Biol 58: 15-18
4. A receptor function. Pharmacol Biochem Behav 45:423-428
5. A receptors. J Neuroendocrinol 7:171-177
6. Brockington IF, Meakin CJ (1994) Clinical clues to the aetiology of puerperal psychosis. Prog Neuropsychopharmacol Biol Psychiatry 18:417-429
7. Brunello N, Masotto C, Steardo L, Markstein R, Racagni G (1995) New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13:177-213
8. Davis M, Mansbach RS, Swerdlow NR, Campean S, Braff DL, Geyer MA (1990) Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology 102:1-4
9. Di Paolo T (1994) Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5:27-42
10. Dluzen DE, Ramirez VD (1990) In vitro progesterone modulates amphetamine-stimulated dopamine release from the corpus striatum of castrated male rats treated with estrogen. Neuroendocrinology 52:517-520
11. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889-895
12. Hrench-Mullen JMH, Danks P, Spence KT (1994) Neurosteroids modulate calcium currents in hippocampal CA 1 neurons via a pertussis toxin-sensitive G-protein-coupled mechanism. J Neurosci 14:1963-1977
13. Friess E, Tagaya H, Trachsel L, Holsboer F, Rupprecht R (1997) Progesterone-induced changes in sleep in male subjects. Am J Physiol 272:E885-E891
14. 2 dopamine receptor messenger RNA in rat brain. Neurosci 69: 159-166
15. Häfner H, Riecher-Rössler A, an der Heiden W, Maurer K, Fätkenheuer B, Löffler W (1993) Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 23:925-940
16. Hallonquist JD, Seeman MV, Lang M, Rector NA (1993) Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 33:207-209
17. Harris B, Lovett L, Newcombe RG, Read GF, Walker R, Riad-Fahmy D (1994) Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II. BMJ 308: 949-953
18. Kavaliers M, Wiebe JP (1987) Analgesic effects of the progesterone metabolite 3α-hydroxy-5α-pregnan-20-one and possible modes of action in mice. Brain Res 415:393-398
19. Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94: 507-522
20. Kinon BJ, Lieberman JA (1996) Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology 124:2-34
21. Koch M, Bubser M (1994) Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol. Eur J Neurosci 6:1837-1845
22. Kohama SG, Bethea CL (1995) Steroid regulation of tyrosine hydroxylase messenger ribonucleic acid in dopaminergic subpopulations of monkey hypothalamus. Endocrinology 136: 1790-1800
23. Krijzer F, Koopman P, Olivier B (1993) Classification of psychotropic drugs on pharmacoelectrocorticographic studies in vigilance-controlled rats. Neuropsychobiology 28:122-137
24. A receptor function. Trends Pharmacol Sci 16:295-303
25. A receptor modulators. Am J Physiol 271: E763-E772
26. Lancel M, Faulhaber J, Schiffelholz T, Romeo E, di Michele F, Holsboer F, Rupprecht R (1997) Allopregnanolone affects sleep in a benzodiazepine-like fashion. J Pharmacol Exp Ther 282: 1213-1318
27. Lewis EJ, Harrington CA, Chikaraishi DM (1987) Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP. Proc Natl Acad Sci USA 84:3350-3554
28. 1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 59:229-239
29. Merryman W, Boiman R, Barnes L, Rothschild I (1954) Progesterone "anaesthesia" in human subjects. J Clin Endocrinol Metab 14:1567-1569
30. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci USA 92:3774-3778
31. Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6: 2311-2322
32. Ramirez VD, Zheng J (1996) Membrane sex-steroid receptors in the brain. Front Neuroendocrinol 17:402-439
33. Rigdon GC (1990) Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strains. Psychopharmacology 102:419-421
34. Rodriguez-Sierra JF, Hagley MT, Hendricks SE (1986) Anxiolytic effects of progesterone are sexually dimorphic. Life Sci 38: 1841-1845
35. Rupprecht R (1997) The neuropsychopharmacological potential of neuroactive steroids. J Psychiatr Res 31:297-314
36. Rupprecht R, Reul JMHM, Trapp T, van Steensel B, Wetzel C, Damm K, Zieglgänsberger W, Holsboer F (1993a) Progesterone receptor-mediated effects of neuroactive steroids. Neuron 11: 523-530
37. Rupprecht R, Reul JMHM, van Steensel B, Spengler D, Söder M, Berning B, Holsboer F, Damm K (1993b) Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur J Pharmacol [Mol Pharmacol Sec] 247:145-154
38. Schmidt HJ (1943) The use of progesterone in the treatment of postpartum psychosis. JAMA 121:190-193
39. Shoaib M, Spanagel R, Stöhr T, Shippenberg TS (1995) Strain differences in the rewarding and dopamine-releasing effects of morphine in rats. Psychopharmacology 117:240-247
40. Su T-P, London ED, Jaffe JH (1989) Steroid binding at σ-opioid receptors. Science 246:1635-1638
41. Swerdlow NR, Geyer MA (1993) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 741-744
42. Swerdlow NR, Geyer M, Braff DL, Koob GF (1986) Central dopamine hyperactivity in rats mimics abnormal acoustic startle in schizophrenics. Biol Psychiatry 21:23-33
43. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139-154
44. Treit D (1985) Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9:203-222
45. Valera S, Ballivet M, Bertrand D (1992) Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 89:9949-9953
46. Varty GB, Higgins GA (1995) Examination of drug-induced and isolation-induced disruption of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology 122:15-26
47. 3 receptor. Mol Endocrinol 12:1441-1451
48. Wieland S, Belluzi JD, Stein L, Lan NC (1995) Comparative behavioral characterization of the neuroactive steroids 3α-OH,5α-pregnan-20-one and 3α-OH,5β-pregnan-20-one in rodents. Psychopharmacology 118:65-71